Literature DB >> 7940126

The importance of the timing of a gap in radiotherapy of squamous cell carcinomas of the head and neck.

T Herrmann1, A Jakubek, K R Trott.   

Abstract

AIM: This paper analyses whether the timing of interruptions during radiotherapy of squamous cell carcinomas of the head and neck influences treatment results. PATIENTS AND METHODS: Hundred and ninety-two patients irradiated with curative intent between 1975 and 1985 (63% after surgery and 37 as primary treatment) were analysed with regard to the occurrence, timing, duration and causes of treatment interruptions. In a multivariate analysis, these factors as well as stage, site, extent of surgery etc. were related to 5-year survival rates.
RESULTS: Interruptions of the prescribed course of radiotherapy decreased the survival rate from 61% to 28%. No adverse effect of a break was seen if it occurred during the first 3 weeks whereas survival dropped to 18 to 25% with a break later in the course of radiotherapy.
CONCLUSION: Timing of treatment interruption in squamous cell carcinomas is a crucial factor determining the chances of tumor cure. The detrimental effect of treatment interruptions increases as treatment progresses. This finding supports the hypothesis that tumor clonogen repopulation accelerates towards the end of radiotherapy of squamous cell carcinomas.

Entities:  

Mesh:

Year:  1994        PMID: 7940126

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  13 in total

1.  Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays.

Authors:  M Maciá I Garau; J Solé Monné; M J Cambra Serés; C Monfà Binefa; M Peraire Llopis
Journal:  Clin Transl Oncol       Date:  2009-05       Impact factor: 3.405

Review 2.  [The therapeutic management of radiogenic oral mucositis].

Authors:  W Dörr; I Dölling-Jochem; M Baumann; T Herrmann
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

3.  [Prevention of radiochemotherapy-induced mucositis. Value of the prophylactic mouth rinsing with PVP-iodine solution].

Authors:  I A Adamietz; R Rahn; H D Böttcher; V Schäfer; K Reimer; W Fleischer
Journal:  Strahlenther Onkol       Date:  1998-03       Impact factor: 3.621

4.  The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancers.

Authors:  Alisa Rybkin; Jung Julie Kang; Anna Lee; Sarin Kitpanit; Ming Fan; Nader Mohamed; Olivia Cartano; Kaveh Zakeri; Daphna Gelblum; Eric Sherman; Lara Dunn; Jay Boyle; Richard Wong; Linda Chen; Yao Yu; Sean M McBride; C Jillian Tsai; Nadeem Riaz; Nancy Y Lee
Journal:  Head Neck       Date:  2021-09-29       Impact factor: 3.821

5.  Treatment-Interval Changes in Serum Levels of Albumin and Histidine Correlated with Treatment Interruption in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Completing Chemoradiotherapy under Recommended Calorie and Protein Provision.

Authors:  Chao-Hung Wang; Hang Huong Ling; Min-Hui Liu; Yi-Ping Pan; Pei-Hung Chang; Yu-Ching Lin; Wen-Chi Chou; Chia-Lin Peng; Kun-Yun Yeh
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

6.  The effect of preventive oral care on treatment outcomes of a cohort of oral cancer patients.

Authors:  Marilia Oliveira Morais; Marcela Ramos Abrahão Elias; Cláudio Rodrigues Leles; Juliana Castro Dourado Pinezi; Elismauro Francisco Mendonça
Journal:  Support Care Cancer       Date:  2015-09-26       Impact factor: 3.603

7.  A traditional Japanese medicine--Hangeshashinto (TJ-14)--alleviates chemoradiation-induced mucositis and improves rates of treatment completion.

Authors:  Taku Yamashita; Koji Araki; Masayuki Tomifuji; Daisuke Kamide; Yuya Tanaka; Akihiro Shiotani
Journal:  Support Care Cancer       Date:  2014-06-19       Impact factor: 3.603

8.  Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.

Authors:  Koji Harada; Tarannum Ferdous; Daiju Horinaga; Kenichiro Uchida; Takamitsu Mano; Katsuaki Mishima; SungChul Park; Hideki Hanazawa; Shotaro Takahashi; Atsumi Okita; Misaki Fukunaga; Junko Maruta; Naoko Kami; Keiko Shibuya; Yoshiya Ueyama
Journal:  Support Care Cancer       Date:  2015-08-07       Impact factor: 3.603

Review 9.  Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature.

Authors:  José A González Ferreira; Javier Jaén Olasolo; Ignacio Azinovic; Branislav Jeremic
Journal:  Rep Pract Oncol Radiother       Date:  2015-07-04

10.  Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck.

Authors:  Hidenori Kimura; Satoshi Hamauchi; Sadayuki Kawai; Yusuke Onozawa; Hirofumi Yasui; Aiko Yamashita; Hirofumi Ogawa; Tsuyoshi Onoe; Tomoyuki Kamijo; Yoshiyuki Iida; Tetsuro Onitsuka; Tomoya Yokota
Journal:  Int J Clin Oncol       Date:  2019-10-16       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.